Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Meanwhile, a treatment with ZERO SAE's in over 800

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155128
(Total Views: 598)
Posted On: 05/28/2020 8:22:06 AM
Avatar
Posted By: Cycl2R
Re: dejavu #35732
Meanwhile, a treatment with ZERO SAE's in over 800 HIV patients, over 5 years, cannot get a compassionate use designation.

Read More: https://investorshangout.com/post/view?id=577...z6Njf44Tna



And isn't it touching that the same "best people"--who had accepted remdesivir as a "new standard of care" and didn't say a word when the HQ was announced as the solution to Covid-19--finally got religion and now cared only about "science"? To the extent that they "recommended" Cytodyn against applying for compassionate use BECAUSE it could slow down our enrollments and be detrimental to the progress medical science! When I first heard about this from Dr. Pourhassan I felt ashamed because of my cynicism about the FDA and my silly (to say the least!) "conspiracy theories" about our democratically elected leaders and their appointees. But then I asked myself again: Why Dr. Lalezari sounded so pissed off with the FDA when they twice rejected his request for Compassionate Use back in early April. I also asked myself what happened to the rest of those 400 sick people who were screened by Novant and were denied participation in the trials because they apparently did not satisfy all "scientific" parameters of the studies? How did they do, those 380 or so? Now in the light of these questions I am no longer sure I must be ashamed of my suspicions about the "best people." Perhaps, I got to go back to square one of my thinking about them-- the imperative of deniability. If the FDA granted us the compassionate use, this would immediately and significantly increase our visibility and hopes for the cure. If the FDA formally denied our request this could raise questions later, especially in the scenario of leronlimab's eventual success and recognition. This is a no-no for the principle of deniability. So instead they gave us a friendly advice not apply for compassionate use ... for the sake of "science" and our best interests. Off the record. With the best intentions of the "best people."


(3)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us